# Riot Platforms, Inc.: financial statements, quarterly

RIOT · Nasdaq · CIK 1167419 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/riot.md) · [Financials](/companies/riot/financials.md) · [Filings](/companies/riot/filings.md) · [Insiders](/companies/riot/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/riot/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [51.9](/filings/0001558370-24-014179.md) | [78.8 d](/filings/0001104659-26-022322.md) | [79.3](/filings/0001558370-25-006119.md) | [70.0](/filings/0001558370-25-009896.md) | [84.8](/filings/0001104659-25-104466.md) | [143 d](/filings/0001104659-26-022322.md) | [161](/filings/0001104659-26-053120.md) | [153](/filings/0001104659-26-093448.md) | [180](/filings/0001104659-25-104466.md) | [153 d](/filings/0001104659-26-022322.md) | [167](/filings/0001104659-26-053120.md) | [174](/filings/0001104659-26-093448.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [29.1](/filings/0001558370-24-014179.md) | [38.8 d](/filings/0001104659-26-022322.md) | [57.7](/filings/0001558370-25-006119.md) | [61.2](/filings/0001558370-25-009896.md) | [66.9](/filings/0001104659-25-104466.md) | [81.1 d](/filings/0001104659-26-022322.md) | [71.4](/filings/0001104659-26-053120.md) | [75.9](/filings/0001104659-26-093448.md) | [69.8](/filings/0001104659-25-104466.md) | [81.6 d](/filings/0001104659-26-022322.md) | [76.2](/filings/0001104659-26-053120.md) | [82.0](/filings/0001104659-26-093448.md) |
| Operating income | $m | [(82.5)](/filings/0001558370-24-014179.md) | [34.3 d](/filings/0001104659-26-022322.md) | [204](/filings/0001558370-25-006119.md) | [(117)](/filings/0001558370-25-009896.md) | [(122)](/filings/0001104659-25-104466.md) | [188 d](/filings/0001104659-26-022322.md) | [(234)](/filings/0001104659-26-053120.md) | [216](/filings/0001104659-26-093448.md) | [80.1](/filings/0001104659-25-104466.md) | [(684) d](/filings/0001104659-26-022322.md) | [(500)](/filings/0001104659-26-053120.md) | [(239)](/filings/0001104659-26-093448.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.2)](/filings/0001558370-24-014179.md) | [(0.1) d](/filings/0001104659-26-022322.md) | [(0.0)](/filings/0001558370-24-006400.md) | [0.1](/filings/0001558370-24-010495.md) | [0.0](/filings/0001558370-24-014179.md) | [0.7 d](/filings/0001104659-26-022322.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(80.0)](/filings/0001558370-24-014179.md) | [39.4 d](/filings/0001104659-26-022322.md) | [212](/filings/0001558370-25-006119.md) | [(84.4)](/filings/0001558370-25-009896.md) | [(154)](/filings/0001104659-25-104466.md) | [136 d](/filings/0001104659-26-022322.md) | [(296)](/filings/0001104659-26-053120.md) | [219](/filings/0001104659-26-093448.md) | [104](/filings/0001104659-25-104466.md) | [(691) d](/filings/0001104659-26-022322.md) | [(500)](/filings/0001104659-26-053120.md) | [(237)](/filings/0001104659-26-093448.md) |
| Diluted EPS | $ per share | [(0.44)](/filings/0001558370-24-014179.md) | not reported | [0.51](/filings/0001558370-25-009896.md) | [(0.32)](/filings/0001558370-25-009896.md) | [(0.54)](/filings/0001104659-25-104466.md) | not reported | [(0.90)](/filings/0001104659-26-053120.md) | [0.58](/filings/0001104659-26-093448.md) | [0.26](/filings/0001104659-25-104466.md) | not reported | [(1.44)](/filings/0001104659-26-053120.md) | [(0.68)](/filings/0001104659-26-093448.md) |
| Basic EPS | $ per share | [(0.44)](/filings/0001558370-24-014179.md) | not reported | [0.51](/filings/0001558370-25-009896.md) | [(0.32)](/filings/0001558370-25-009896.md) | [(0.54)](/filings/0001104659-25-104466.md) | not reported | [(0.90)](/filings/0001104659-26-053120.md) | [0.65](/filings/0001104659-26-093448.md) | [0.30](/filings/0001104659-25-104466.md) | not reported | [(1.44)](/filings/0001104659-26-053120.md) | [(0.68)](/filings/0001104659-26-093448.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [290](/filings/0001558370-24-014179.md) | [597](/filings/0001104659-26-022322.md) | [688](/filings/0001558370-25-006119.md) | [481](/filings/0001558370-25-009896.md) | [356](/filings/0001104659-25-104466.md) | [278](/filings/0001104659-26-093448.md) | [164](/filings/0001104659-26-053120.md) | [255](/filings/0001104659-26-093448.md) | [331](/filings/0001104659-25-104466.md) | [234](/filings/0001104659-26-093448.md) | [206](/filings/0001104659-26-053120.md) | [471](/filings/0001104659-26-093448.md) |
| Current assets | $m | [513](/filings/0001558370-23-018316.md) | [1,009](/filings/0001558370-25-001888.md) | [785](/filings/0001558370-24-006400.md) | [744](/filings/0001558370-24-010495.md) | [717](/filings/0001558370-24-014179.md) | [599](/filings/0001104659-26-022322.md) | [450](/filings/0001558370-25-006119.md) | [516](/filings/0001558370-25-009896.md) | [529](/filings/0001104659-25-104466.md) | [449](/filings/0001104659-26-093448.md) | [463](/filings/0001104659-26-053120.md) | [726](/filings/0001104659-26-093448.md) |
| Total assets | $m | [1,455](/filings/0001558370-23-018316.md) | [2,051](/filings/0001558370-25-001888.md) | [2,611](/filings/0001558370-24-006400.md) | [2,724](/filings/0001558370-24-010495.md) | [2,922](/filings/0001558370-24-014179.md) | [3,935](/filings/0001104659-26-022322.md) | [3,719](/filings/0001558370-25-006119.md) | [4,285](/filings/0001558370-25-009896.md) | [4,479](/filings/0001104659-25-104466.md) | [3,937](/filings/0001104659-26-093448.md) | [3,438](/filings/0001104659-26-053120.md) | [3,264](/filings/0001104659-26-093448.md) |
| Current liabilities | $m | [71.1](/filings/0001558370-23-018316.md) | [121](/filings/0001558370-25-001888.md) | [92.6](/filings/0001558370-24-006400.md) | [97.3](/filings/0001558370-24-010495.md) | [126](/filings/0001558370-24-014179.md) | [160](/filings/0001104659-26-022322.md) | [139](/filings/0001558370-25-006119.md) | [375](/filings/0001558370-25-009896.md) | [359](/filings/0001104659-25-104466.md) | [470](/filings/0001104659-26-093448.md) | [429](/filings/0001104659-26-053120.md) | [458](/filings/0001104659-26-093448.md) |
| Total liabilities | $m | [115](/filings/0001558370-23-018316.md) | [163](/filings/0001558370-25-001888.md) | [136](/filings/0001558370-24-006400.md) | [139](/filings/0001558370-24-010495.md) | [173](/filings/0001558370-24-014179.md) | [792](/filings/0001104659-26-022322.md) | [774](/filings/0001558370-25-006119.md) | [989](/filings/0001558370-25-009896.md) | [974](/filings/0001104659-25-104466.md) | [1,078](/filings/0001104659-26-093448.md) | [1,043](/filings/0001104659-26-053120.md) | [1,071](/filings/0001104659-26-093448.md) |
| Long-term debt | $m | not reported | [0.5](/filings/0001558370-25-001888.md) | not reported | not reported | [5.6](/filings/0001558370-24-014179.md) | [584](/filings/0001104659-26-022322.md) | [585](/filings/0001558370-25-006119.md) | [586](/filings/0001558370-25-009896.md) | [587](/filings/0001104659-25-104466.md) | [587](/filings/0001104659-26-093448.md) | [588](/filings/0001104659-26-053120.md) | [588](/filings/0001104659-26-093448.md) |
| Current portion of debt | $m | not reported | [0.3](/filings/0001558370-25-001888.md) | not reported | not reported | [0.7](/filings/0001558370-24-014179.md) | [0.3](/filings/0001104659-26-022322.md) | [0.3](/filings/0001558370-25-006119.md) | [253](/filings/0001558370-25-009896.md) | [253](/filings/0001104659-25-104466.md) | [254](/filings/0001104659-26-093448.md) | [255](/filings/0001104659-26-053120.md) | [255](/filings/0001104659-26-093448.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,380](/filings/0001558370-24-014179.md) | [1,888](/filings/0001104659-26-022322.md) | [2,475](/filings/0001558370-25-009896.md) | [2,585](/filings/0001104659-25-104466.md) | [2,749](/filings/0001104659-25-104466.md) | [3,144](/filings/0001104659-26-093448.md) | [2,945](/filings/0001104659-26-093448.md) | [3,296](/filings/0001104659-26-093448.md) | [3,505](/filings/0001104659-25-104466.md) | [2,858](/filings/0001104659-26-093448.md) | [2,395](/filings/0001104659-26-093448.md) | [2,193](/filings/0001104659-26-093448.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.2) d](/filings/0001558370-24-014179.md) | [45.0 d](/filings/0001104659-26-022322.md) | [(57.9)](/filings/0001558370-25-006119.md) | [(42.5) d](/filings/0001558370-25-009896.md) | [(56.3) d](/filings/0001104659-25-104466.md) | [(98.4) d](/filings/0001104659-26-022322.md) | [(122)](/filings/0001104659-26-053120.md) | [(231) d](/filings/0001104659-26-093448.md) | [(114) d](/filings/0001104659-25-104466.md) | [(106) d](/filings/0001104659-26-022322.md) | [(183)](/filings/0001104659-26-053120.md) | [(90.1) d](/filings/0001104659-26-093448.md) |
| Capital expenditure | $m | [40.8 d](/filings/0001558370-24-014179.md) | [45.5 d](/filings/0001104659-26-022322.md) | [57.3](/filings/0001558370-25-006119.md) | [53.5 d](/filings/0001558370-25-009896.md) | [71.3 d](/filings/0001104659-25-104466.md) | [58.2 d](/filings/0001104659-26-022322.md) | [32.9](/filings/0001104659-26-053120.md) | [60.4 d](/filings/0001104659-26-093448.md) | [25.7 d](/filings/0001104659-25-104466.md) | [82.5 d](/filings/0001104659-26-022322.md) | [115](/filings/0001104659-26-053120.md) | [60.7 d](/filings/0001104659-26-093448.md) |
| Share repurchases | $m | [1.0 d](/filings/0001558370-24-014179.md) | [0.1 d](/filings/0001104659-26-022322.md) | [2.0](/filings/0001558370-25-006119.md) | [8.8 d](/filings/0001558370-25-009896.md) | [0.7 d](/filings/0001104659-25-104466.md) | [0.1 d](/filings/0001104659-26-022322.md) | [0.5](/filings/0001104659-26-053120.md) | [0.1 d](/filings/0001104659-26-093448.md) | [2.6 d](/filings/0001104659-25-104466.md) | [1.1 d](/filings/0001104659-26-022322.md) | [2.0](/filings/0001104659-26-053120.md) | [0.5 d](/filings/0001104659-26-093448.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [154](/filings/0001558370-23-018316.md) | [172](/filings/0001558370-24-006400.md) | [167](/filings/0001558370-24-010495.md) | [181](/filings/0001558370-24-014179.md) | [250](/filings/0001558370-25-009896.md) | [265](/filings/0001558370-25-009896.md) | [286](/filings/0001104659-25-104466.md) | [330](/filings/0001104659-26-053120.md) | [383](/filings/0001104659-26-093448.md) | [403](/filings/0001104659-25-104466.md) | [348](/filings/0001104659-26-053120.md) | [348](/filings/0001104659-26-093448.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 375,258,935 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093448.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.